Delivery Order SPE2DB22D3010-SPE2DB25FP3KM
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,532.48 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on August 29, 2025. This firm fixed-price, competitively awarded contract is scheduled for completion by September 2, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $43,457.38 to AmerisourceBergen Drug Corp for Entresto 49 mg-51 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and represents pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units) valued at $10,707.66. This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by September 9, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Entresto 24 mg-26 mg tablets in quantities of 60 units, with a contract ceiling value of $7,312.22. This firm fixed-price delivery order, awarded without set-aside designation through competitive procurement, is part of AmerisourceBergen's broader federal pharmaceutical supply operations supporting military and veteran healthcare systems. The order is scheduled for...
- The U.S. Department of Defense Medical Supply Chain awarded a $22,354.14 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count unit) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price, non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a $24,605.54 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract type. This delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Entresto 49 mg-51 mg tablets in quantities of 60 units. This competitive, non-set-aside contract is valued at $63,436.94 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and represents a major...
- The Defense Logistics Agency awarded a delivery order valued at $11,649.95 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count) under a firm fixed price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and represents a non-set-aside, competitively awarded contract. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...